The European Crohn’s and Colitis Organisation (ECCO) Congress has become the leading world congress for Inflammatory Bowel Diseases. This year’s virtual meeting, taking place from July 2-3 and July 8-10, will include a highly diverse program with a major focus on precision medicine for IBD.
Experts from Evidera’s Evidence Synthesis, Modeling & Communication team are presenting an ePoster titled, “Optimising Vedolizumab in Treatment Sequences for Crohn’s Disease: Results from a Simulation Model Using Real-World Evidence.” Authors include: Louis E, Nikolaou A, Litkiewwicz M, Agboton C, Wang S, Armuzzi A